Uranium Energy Corp. (UEC) Taps World’s First Significant Alternative Energy Boom
Uranium Energy Corp., a uranium exploration and development company controlling one of the largest databases of historic uranium exploration and…
Blog
Flint Telecom Group, Inc. (FLTT.OB) Signs $10 Million Reserve Equity Financing Line
Flint Telecom Group, Inc. announced yesterday that they completed a Reserve Equity Finance Agreement with New York based AGS Capital…
Options Media Group Holdings, Inc. (OPMG.OB) Video Chart for Friday, June 25, 2010
We were requested to take a look at OPMG. There's a good support level at $.025 and resistance coming from…
General Environmental Management, Inc. (GEVI.OB) to Focus Entirely on Waste-to-Energy Project in Brazil
General Environmental Management Inc. announced this morning that it will focus all efforts on the Bio-Energy Solutions Group, Inc. (BESG)…
Spectrum Control, Inc. (SPEC) Reports Higher Earnings and Revenue in Second Quarter
Spectrum Control, Inc. reported net income of $3.3 million, or $0.25 per diluted share, in the second quarter of fiscal…
TechPrecision Corp. (TPCS) Reports Higher Backlog in Fiscal 2010
TechPrecision Corp. reported net income of $700,000, or $0.03 per diluted share, in fiscal year 2010, which ended on 3/31/2010.…
Thwapr, Inc. (THWI.OB) Teams up with Kingdom Entertainment Group to Leverage Mobile Content Platform
Thwapr, Inc., www.thwapr.com – developers of the powerful mobile video sharing platform of the same name which allows quality video…
National Automation Services, Inc. (NASV.PK) Announces Filing of S-1 Registration
National Automation Services, Inc. announced earlier today that it has filed a registration statement on Form S-1 with the SEC…
Applied DNA Sciences, Inc. (APDN.OB) Partners with Bilcare Technologies to Offer Real-Time Supply Chain Security and Authentication Solution
Applied DNA Sciences, Inc., www.adnas.com – the provider of security solutions based on patented DNA biometrics, announced today a definitive…
PharmaGap, Inc. (PHRGF.PK) In-Vitro Testing Shows Significant Reduction in Melanoma Cancer Cell Growth
Biotechnology company PharmaGap Inc. today announced 80 percent average growth inhibition in in-vitro trials of its lead cancer drug GAP-107B8…